NUVL
USDNuvalent Inc. Class A Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$94.250
High
$95.225
Low
$92.075
Volume
0.28M
Company Fundamentals
Market Cap
6.7B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.46M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Nuvalent to Present Patient-Reported Outcomes Data from ARROS-1 Trial of ROS1-Selective Inhibitor, Zidesamtinib, at 2025 IASLC ASCO North America Conference on Lung Cancer
Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven...
UBS Maintains Buy on Nuvalent, Raises Price Target to $132
UBS analyst David Dai maintains Nuvalent with a Buy and raises the price target from $114 to $132.
Nuvalent Highlights Recent Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports Third Quarter 2025 Financial Results
Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven...
Piper Sandler Maintains Overweight on Nuvalent, Raises Price Target to $128
Piper Sandler analyst Kelsey Goodwin maintains Nuvalent with a Overweight and raises the price target from $112 to $128.
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.